Lyell Immunopharma Inc

NAS:LYEL (USA)   Ordinary Shares
$ 2.38 -0.06 (-2.46%) 12:06 PM EST
At Loss
P/B:
0.86
Market Cap:
$ 599.45M
Enterprise V:
$ 96.45M
Volume:
221.70K
Avg Vol (2M):
1.07M
Volume:
221.70K
At Loss
Avg Vol (2M):
1.07M

Business Description

Lyell Immunopharma Inc
NAICS : 325412 SIC : 2834
ISIN : US55083R1041

Share Class Description:

LYEL: Ordinary Shares
Description
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).
Name Current Vs Industry Vs History
Cash-To-Debt 9.82
Equity-to-Asset 0.88
Debt-to-Equity 0.08
Debt-to-EBITDA -0.32
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.97
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 385.4
3-Year EBITDA Growth Rate -12.8
3-Year EPS without NRI Growth Rate -5.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 87.18
9-Day RSI 76.28
14-Day RSI 68.91
6-1 Month Momentum % -5.99
12-1 Month Momentum % -13.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.74
Quick Ratio 16.74
Cash Ratio 16.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Shareholder Yield % 0.77

Financials (Next Earnings Date:2024-02-28 Est.)

LYEL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LYEL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lyell Immunopharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 48.503
EPS (TTM) ($) -0.76
Beta 0
Volatility % 86.81
14-Day RSI 68.91
14-Day ATR ($) 0.15296
20-Day SMA ($) 1.92025
12-1 Month Momentum % -13.92
52-Week Range ($) 1.32 - 3.97
Shares Outstanding (Mil) 251.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lyell Immunopharma Inc Filings

Filing Date Document Date Form
No Filing Data

Lyell Immunopharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Lyell Immunopharma Inc Frequently Asked Questions

What is Lyell Immunopharma Inc(LYEL)'s stock price today?
The current price of LYEL is $2.38. The 52 week high of LYEL is $3.97 and 52 week low is $1.32.
When is next earnings date of Lyell Immunopharma Inc(LYEL)?
The next earnings date of Lyell Immunopharma Inc(LYEL) is 2024-02-28 Est..
Does Lyell Immunopharma Inc(LYEL) pay dividends? If so, how much?
Lyell Immunopharma Inc(LYEL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1